https://www.selleckchem.com/pr....oducts/elenestinib-p
aintenance therapy than either histologic or endoscopic improvement alone. ClinicalTrials.gov number NCT02407236. Data from the UNIFI program of ustekinumab in patients with UC treated with ustekinumab indicated the achievement of histo-endoscopic mucosal healing after induction therapy is associated with lower disease activity at the end of maintenance therapy than either histologic or endoscopic improvement alone. ClinicalTrials.gov number NCT02407236.One hundred and twenty one-day-old chukar partridges were randomly div
Like
Comment
Share
